: Tuberculosis (TB) persists as a global health concern due to high prevalence of infection and drug resistance. More detailed knowledge of TB pathogenesis is needed to unravel novel approaches for prevention and treatment. Early antimicrobial mechanisms which are part of the innate immune response system are crucial for the outcome of the infection with Mycobacterium tuberculosis (Mtb). In this application, we investigate a novel mechanism, how human macrophages (Mp), the primary host cell of Mtb, inhibit growth of Mtb when they undergo apoptosis. Our preliminary data show that apoptosis of the Mp infected with Mtb is associated with their capacity to exhibit strong anti-mycobacterial activity, whereas necrosis promotes extracellular bacterial growth. We further showed that virulent Mtb are able to avoid host Mp apoptosis, whereas the attenuated Mtb strain H37Ra strongly induces apoptosis. We postulate that Mp-apoptosis 1) restricts Mtb growth by sequestering the bacilli within apoptotic bodies and 2) packages Mtb for rapid and efficient elimination by freshly recruited phagocytes. Uptake of free Mtb is also associated with arrested phagosome maturation and unrestricted intracellular growth. We think that Mtb packaged in apoptotic bodies are eliminated more effectively by the defense systems of the Mp. We will examine possible cooperative effector systems when uninfected Mp are presented with Mtb contained in apoptotic bodies. We have also found that Mtb-induced Mp apoptosis and associated anti-mycobacterial activity are dependent on the concerted action of tumor necrosis factor a, cytosolic phospholipase A2, and on intra-cellular Calevels, but the specific role and function of these mechanisms is not understood. We will investigate the role of these mechanisms in induction of apoptosis and anti-mycobacterial activity and how attenuated and virulent Mtb differ in the activation of these processes. The goals, thus, are to 1) determine how avirulent Mtb induce apoptosis and antimycobacterial mechanisms and how virulent Mtb avoid it, 2) to find out how apoptotic Mp block growth of Mtb and 3) to define the anti-mycobacterial mechanisms of naive Mp after uptake of apoptotic infected Mp.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AI050216-01
Application #
6364517
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Program Officer
Sizemore, Christine F
Project Start
2001-09-01
Project End
2002-08-31
Budget Start
2001-09-01
Budget End
2002-08-31
Support Year
1
Fiscal Year
2001
Total Cost
$335,525
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Zhao, X; Khan, N; Gan, H et al. (2017) Bcl-xL mediates RIPK3-dependent necrosis in M. tuberculosis-infected macrophages. Mucosal Immunol 10:1553-1568
Behar, Samuel M; Martin, Constance J; Nunes-Alves, Cláudio et al. (2011) Lipids, apoptosis, and cross-presentation: links in the chain of host defense against Mycobacterium tuberculosis. Microbes Infect 13:749-56
Behar, S M; Martin, C J; Booty, M G et al. (2011) Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. Mucosal Immunol 4:279-87
Divangahi, Maziar; Chen, Minjian; Gan, Huixian et al. (2009) Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat Immunol 10:899-906